[go: up one dir, main page]

BRPI0409362A - combinação simbiótica - Google Patents

combinação simbiótica

Info

Publication number
BRPI0409362A
BRPI0409362A BRPI0409362-3A BRPI0409362A BRPI0409362A BR PI0409362 A BRPI0409362 A BR PI0409362A BR PI0409362 A BRPI0409362 A BR PI0409362A BR PI0409362 A BRPI0409362 A BR PI0409362A
Authority
BR
Brazil
Prior art keywords
symbiotic combination
symbiotic
combination
oligosaccaride
digestible
Prior art date
Application number
BRPI0409362-3A
Other languages
English (en)
Inventor
Michael Beer
Glenn R Gibson
Christopher Smejka
Original Assignee
Novartis Ag
Univ Reading
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Univ Reading filed Critical Novartis Ag
Publication of BRPI0409362A publication Critical patent/BRPI0409362A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Botany (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"COMBINAçãO SIMBIóTICA". A presente invenção refere-se à composição compreendendo uma cepa de Lactobacillus e um oligossacarídeo não-digerível.
BRPI0409362-3A 2003-04-08 2004-04-07 combinação simbiótica BRPI0409362A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0308104.9A GB0308104D0 (en) 2003-04-08 2003-04-08 Organic compounds
PCT/EP2004/003736 WO2004089115A1 (en) 2003-04-08 2004-04-07 Synbiotic combination

Publications (1)

Publication Number Publication Date
BRPI0409362A true BRPI0409362A (pt) 2006-04-25

Family

ID=9956413

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0409362-3A BRPI0409362A (pt) 2003-04-08 2004-04-07 combinação simbiótica

Country Status (15)

Country Link
US (1) US20060165670A1 (pt)
EP (1) EP1613180B1 (pt)
JP (1) JP2006522766A (pt)
CN (1) CN1784151A (pt)
AT (1) ATE384448T1 (pt)
AU (1) AU2004228936B2 (pt)
BR (1) BRPI0409362A (pt)
CA (1) CA2521380A1 (pt)
DE (1) DE602004011497D1 (pt)
GB (1) GB0308104D0 (pt)
MX (1) MXPA05010862A (pt)
NZ (1) NZ542717A (pt)
RU (1) RU2005134174A (pt)
WO (1) WO2004089115A1 (pt)
ZA (1) ZA200507743B (pt)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7029702B2 (en) * 1998-07-07 2006-04-18 Ritter Natural Sciences Llc Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
WO2006012536A2 (en) * 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
EP1656839A1 (en) * 2004-11-11 2006-05-17 N.V. Nutricia Nutrition containing lipid blend
KR101355266B1 (ko) 2005-02-15 2014-02-06 배리 알 골딘 생균 및 분리된 β­글루칸을 포함하는 식품 및 이들의 사용방법
EP1714660A1 (en) 2005-04-21 2006-10-25 N.V. Nutricia Uronic acid and probiotics
EP1885383B1 (en) 2005-05-31 2016-09-21 IAMS Europe B.V. Feline probiotic bifidobacteria
WO2006130187A1 (en) 2005-05-31 2006-12-07 The Iams Company Feline probiotic lactobacilli
NO323665B1 (no) * 2005-06-27 2007-06-18 Pharmalogica As Drikk omfattende fiskeolje og probiotiske bakterier og fremgangsmate for fremstilling.
FR2889057B1 (fr) * 2005-08-01 2008-07-18 Oreal Composition cosmetique et/ou dermatologique pour la prevention et/ou le traitement des peaux sensibles ou seches
RU2445360C2 (ru) * 2005-10-05 2012-03-20 Нестек С.А. Композиция для компенсации задержки роста
JP5030960B2 (ja) * 2005-10-24 2012-09-19 ネステク ソシエテ アノニム 食物繊維製剤及び投与方法
GB0524668D0 (en) * 2005-12-02 2006-01-11 Novartis Ag Organic compounds
PT2076271E (pt) 2006-10-02 2011-12-02 Friesland Brands Bv Inibição de toxinas da cólera por galacto-oligossacáridos (gos)
JP5285852B2 (ja) * 2006-12-28 2013-09-11 株式会社ファンケル Ｄｆａｉｉｉの製造方法及びｄｆａｉｉｉ高含有植物エキス
MX2009008166A (es) 2007-02-01 2009-08-12 Iams Company Metodo para disminuir la inflamacion y estres en un mamifero usando antimetabolitos de glucosa, aguacate o extractos de aguacate.
EP2025248A1 (en) * 2007-07-31 2009-02-18 Fresenius Kabi Deutschland GmbH Cachexia prevention supplement
US20090061008A1 (en) * 2007-08-30 2009-03-05 Levy Mark M Fiber/granule complex for treatment of the gi tract
US10251899B2 (en) 2007-10-08 2019-04-09 Mead Johnson Nutrition Company Method for improving stool characteristics in infants
AU2008340529B2 (en) * 2007-12-20 2012-02-16 Unilever Plc Edible product having an immunostimulating effect
JP5992654B2 (ja) * 2007-12-21 2016-09-14 ニュートリー株式会社 整腸及び／又は便通改善のための組成物
FI121912B (fi) * 2008-02-05 2011-06-15 Valio Oy Probioottien uusi käyttö
PT2265135T (pt) * 2008-03-14 2018-02-21 Nestec Sa Mistura simbiótica
US9771199B2 (en) * 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US20110189148A1 (en) * 2008-06-25 2011-08-04 Ritter Pharmaceuticals, Inc. Lactose compositions with decreased lactose content
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
WO2010008272A1 (en) * 2008-07-15 2010-01-21 N.V. Nutricia Treatment of gut motility disorders
SG10201901259RA (en) 2009-02-24 2019-03-28 Ritter Pharmaceuticals Inc Prebiotic formulations and methods of use
US8785160B2 (en) 2009-02-24 2014-07-22 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
WO2010105207A1 (en) * 2009-03-13 2010-09-16 The Regents Of The University Of California Prebiotic oligosaccharides
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
GB0915315D0 (en) * 2009-09-03 2009-10-07 Univ Manchester Use of non-digestible oligosaccharides
CA2775059A1 (en) * 2009-09-25 2011-03-31 Nestec S.A. Nutritional compositions including theanine and exogenous nucleotides
CN104206946A (zh) 2009-11-12 2014-12-17 雀巢产品技术援助有限公司 用于促进肠微生物群平衡和健康的营养组合物
PH12012501184A1 (en) * 2009-12-29 2012-11-26 Nestec Sa Nutritional compositions comprising fruit flakes containing docosahexaenoic acid
RU2457849C2 (ru) * 2010-01-28 2012-08-10 Геннадий Владимирович Комоско Многофункциональный синбиотический препарат, состоящий из пробиотика на основе лактобактерий, адаптогена на основе гидролизата крови и наносорбента
US20110189342A1 (en) * 2010-02-01 2011-08-04 Jeong Hea-Seok High-purity galactooligosaccharides and uses thereof
FR2955774A1 (fr) 2010-02-02 2011-08-05 Aragan Preparation destinee a traiter l'exces ponderal et les desordres associes et applications de ladite preparation
FI20105824A0 (fi) * 2010-07-26 2010-07-26 Suomen Punainen Risti Veripalv Veriryhmästatuksen käyttö IV
US9125935B1 (en) * 2011-05-31 2015-09-08 Nutech Ventures Probiotics and methods of obtaining same
GB201319531D0 (en) * 2013-11-05 2013-12-18 Optibiotix Health Ltd Composition & methods of screening
CN107404931A (zh) 2015-03-05 2017-11-28 雀巢产品技术援助有限公司 用于改善婴儿或幼儿粪便稠度或频率的组合物
US10751362B2 (en) 2016-07-18 2020-08-25 Metagenics, Inc. Compositions and methods for managing digestive disorders and a healthy microbiome
CN112806577B (zh) * 2019-11-15 2021-11-26 内蒙古伊利实业集团股份有限公司 产丁酸的益生元益生菌增效组合
CN111248443A (zh) * 2020-03-10 2020-06-09 安徽大学 一种具有改善溃疡性结肠炎的合生元组合物及其制剂与应用
CN113678895A (zh) * 2021-08-18 2021-11-23 南昌大学 一种冷藏期具有高抗氧化活性的合生元发酵乳及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6203797B1 (en) * 1998-01-06 2001-03-20 Stephen C. Perry Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome
IT1304170B1 (it) * 1998-12-15 2001-03-08 Novartis Nutrition Ag Composti organici
GB2369777B (en) * 2000-10-05 2004-10-27 St Ivel Ltd Food products with antimicrobial lactic acid bacteria
RU2190015C1 (ru) * 2001-04-27 2002-09-27 Закрытое акционерное общество "Партнер" Штамм lactobacillus brevis ba-13, используемый для приготовления пробиотических препаратов и продуктов питания
GB0124580D0 (en) * 2001-10-12 2001-12-05 Univ Reading New composition

Also Published As

Publication number Publication date
JP2006522766A (ja) 2006-10-05
DE602004011497D1 (de) 2008-03-13
AU2004228936A1 (en) 2004-10-21
NZ542717A (en) 2006-11-30
WO2004089115A1 (en) 2004-10-21
CA2521380A1 (en) 2004-10-21
EP1613180A1 (en) 2006-01-11
RU2005134174A (ru) 2006-07-27
US20060165670A1 (en) 2006-07-27
CN1784151A (zh) 2006-06-07
ZA200507743B (en) 2007-10-31
EP1613180B1 (en) 2008-01-23
AU2004228936B2 (en) 2007-07-12
GB0308104D0 (en) 2003-05-14
MXPA05010862A (es) 2006-03-30
ATE384448T1 (de) 2008-02-15

Similar Documents

Publication Publication Date Title
BRPI0409362A (pt) combinação simbiótica
TW200500012A (en) Novel lactobacillus and use thereof
TW200500081A (en) Novel rotaviruses and use thereof
ITVI20030027A1 (it) Pressacavo.
ITLC20040002A1 (it) P.p.0
SE0203166D0 (sv) Slitfoderelement
GB0326831D0 (en) Friction assembly
TH201000148A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH201000553A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH201000756A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH201000702A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH201000798A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH201000812A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH201000820A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH201000700A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH201000833A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH201000736A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH201000645A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH201000633A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH201000625A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH201000606A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH201000598A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH201000584A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH201000882A (th) สิทธิบัตรยังไม่ประกาศโฆษณา
TH201000559A (th) สิทธิบัตรยังไม่ประกาศโฆษณา

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.

B15K Others concerning applications: alteration of classification

Ipc: A61K 31/702 (2006.01), A23L 33/135 (2016.01), A23L